Bausch & Lomb, the global eye health company, has completed its acquisition of eyeonics, an ophthalmic medical device company headquartered in Aliso Viejo, California.
Subscribe to our email newsletter
Eyeonics now operates as a wholly-owned subsidiary of Bausch & Lomb. Its crystalens intraocular lens (IOL), the first and only FDA-approved accommodating IOL for the treatment of cataracts, joins Bausch & Lomb’s portfolio of innovative ophthalmic surgical products for cataract, vitreoretinal and refractive markets.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.